Itron (NASDAQ:ITRI) Given New $113.00 Price Target at JPMorgan Chase & Co.

Itron (NASDAQ:ITRI) had its target price decreased by JPMorgan Chase & Co. from $133.00 to $113.00 in a report released on Thursday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the scientific and technical instruments company’s stock.

Other analysts have also recently issued reports about the stock. Robert W. Baird set a $128.00 target price on shares of Itron and gave the company an “outperform” rating in a research note on Wednesday, February 18th. Needham & Company LLC assumed coverage on shares of Itron in a research note on Friday, March 6th. They issued a “buy” rating and a $124.00 target price for the company. Oppenheimer lifted their target price on shares of Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday. Weiss Ratings cut shares of Itron from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Finally, Johnson Rice upgraded shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 target price for the company in a research note on Monday, January 5th. Eight investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Itron presently has an average rating of “Moderate Buy” and a consensus price target of $133.10.

Itron Stock Down 0.6%

Shares of Itron stock opened at $97.00 on Thursday. The firm has a market cap of $4.30 billion, a price-to-earnings ratio of 14.90, a P/E/G ratio of 0.85 and a beta of 1.50. The stock has a 50-day simple moving average of $93.84 and a 200-day simple moving average of $101.89. Itron has a 52-week low of $83.51 and a 52-week high of $142.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.80 and a quick ratio of 1.56.

Itron (NASDAQ:ITRI) last issued its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.19 by $0.27. The firm had revenue of $571.66 million for the quarter, compared to analyst estimates of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The company’s revenue for the quarter was down 6.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.35 earnings per share. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, equities research analysts expect that Itron will post 5.33 earnings per share for the current fiscal year.

Insider Transactions at Itron

In related news, CAO David Marshall Wright sold 264 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $100.17, for a total value of $26,444.88. Following the completion of the sale, the chief accounting officer directly owned 9,124 shares in the company, valued at approximately $913,951.08. The trade was a 2.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Laurie Ann Pulatie-Hahn sold 729 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $100.17, for a total value of $73,023.93. Following the completion of the sale, the senior vice president owned 32,950 shares of the company’s stock, valued at approximately $3,300,601.50. This trade represents a 2.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 51,180 shares of company stock worth $5,085,475. 1.77% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Itron

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Pacer Advisors Inc. acquired a new stake in Itron in the 4th quarter worth approximately $12,864,000. Mercer Global Advisors Inc. ADV lifted its holdings in Itron by 18.8% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 2,787 shares of the scientific and technical instruments company’s stock worth $259,000 after purchasing an additional 441 shares during the last quarter. XTX Topco Ltd acquired a new stake in Itron in the 4th quarter worth approximately $1,032,000. Voloridge Investment Management LLC lifted its holdings in Itron by 164.1% in the 4th quarter. Voloridge Investment Management LLC now owns 197,536 shares of the scientific and technical instruments company’s stock worth $18,343,000 after purchasing an additional 122,733 shares during the last quarter. Finally, Symmetry Investments LP acquired a new position in shares of Itron during the fourth quarter worth approximately $3,334,000. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.